<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>Annals of Internal Medicine: Vasculitides Topic Collection</title>
    <link>http://annals.org/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Tue, 04 Oct 2011 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 09 Apr 2013 13:48:14 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@annals.org</managingEditor>
    <webMaster>webmaster@annals.org</webMaster>
    <item>
      <title>Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis</title>
      <link>http://annals.org/article.aspx?articleID=477645</link>
      <pubDate>Tue, 04 Oct 2011 00:00:00 GMT</pubDate>
      <author>Dagna L, Salvo F, Tiraboschi M, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Background:&lt;/div&gt;Because pentraxin-3 (PTX3) is produced by immune and vascular cells in response to proinflammatory signals, it may be a useful biomarker for defining disease activity in patients with Takayasu arteritis.&lt;div class="boxTitle"&gt;Objective:&lt;/div&gt;To compare PTX3 levels in patients who have Takayasu arteritis with those in healthy and infected controls, and to compare accuracy of PTX3 levels with that of C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR) for distinguishing active and inactive disease.&lt;div class="boxTitle"&gt;Design:&lt;/div&gt;Cross-sectional, noninterventional study conducted between September 2005 and October 2008.&lt;div class="boxTitle"&gt;Setting:&lt;/div&gt;Immunology and rheumatology clinic at a university hospital in Italy.&lt;div class="boxTitle"&gt;Patients:&lt;/div&gt;57 consecutive patients with Takayasu arteritis and known disease activity, 57 healthy blood donor controls, and 15 patients with acute infection.&lt;div class="boxTitle"&gt;Measurements:&lt;/div&gt;Disease activity by clinical criteria; plasma PTX3 and CRP levels and ESR.&lt;div class="boxTitle"&gt;Results:&lt;/div&gt;27 patients had active Takayasu arteritis; 30 had inactive disease. Levels of PTX3 were higher in patients with active disease (median, &gt;2.14 ng/mL [range, 0.57 to 48.18 ng/mL]) than in those with inactive disease (median, 0.63 ng/mL [range, 0.00 to 1.64 ng/mL]) and were higher than in healthy patients (median, 0.11 ng/mL [range, 0 to 1.20 ng/mL]) or those with acute infection (median, 0.26 ng/mL [range, 0 to 0.75 ng/mL]). A plasma PTX3 level greater than 1 ng/mL was more accurate than normal thresholds of CRP or ESR for distinguishing active from inactive disease.&lt;div class="boxTitle"&gt;Limitation:&lt;/div&gt;The study excluded patients with unknown or equivocal disease status.&lt;div class="boxTitle"&gt;Conclusion:&lt;/div&gt;Plasma levels of PTX3 could help distinguish active from inactive Takayasu arteritis but should not be adopted for clinical use until the findings are confirmed in a broader spectrum of patients whose disease activity is unknown or equivocal before testing.&lt;div class="boxTitle"&gt;Primary Funding Source:&lt;/div&gt;None.&lt;/span&gt;</description>
      <guid>http://annals.org/article.aspx?articleID=477645</guid>
    </item>
  </channel>
</rss>